百胜中国(09987) - 2024 Q3 - 业绩电话会
2024-11-04 12:00
Financial Data and Key Metrics Changes - System sales grew 4% year over year, with a same-store sales index improving to 97% of the prior year's level [2][8] - Operating profit increased by 18%, and diluted EPS rose by 32% [2][10] - Restaurant margin improved by 50 basis points year over year, while core operating profit margin expanded by 140 basis points [3][8] Business Line Data and Key Metrics Changes - KFC system sales increased by 6% year over year, with same-store sales at 98% of prior year levels [8][10] - Pizza Hut system sales rose by 2% year over year, with same-store sales at 94% of prior year levels [8][10] - Delivery sales grew 18%, accounting for around 40% of the sales mix [3][4] Market Data and Key Metrics Changes - KFC and Pizza Hut have increased their market share on aggregator platforms, while over 70% of total sales come from non-aggregator channels [4][10] - The franchisee mix for KFC's new stores increased from 15% in 2023 to 27% year-to-date, with expectations to reach 40-50% in the coming years [7][17] Company Strategy and Development Direction - The company is focusing on operational efficiency and innovation through initiatives like Project Fresh Eye and Project Red Eye [3][10] - The strategy includes widening price ranges and optimizing delivery to capture underserved markets and enhance customer access [2][12] - The company plans to step up capital returns to shareholders, increasing the target from $3 billion to $4.5 billion over the next three years [11][12] Management's Comments on Operating Environment and Future Outlook - Management remains confident in China's midterm and long-term growth opportunities despite current cautious consumer sentiment [11][19] - The company expects Q4 to be traditionally low in sales and profits but aims to maintain focus on operational efficiency and innovation [11][19] - Management acknowledges the competitive landscape but believes their strategies will allow them to outperform peers [16][19] Other Important Information - The company has returned over $4 billion to shareholders since its spinoff, with more than $1.2 billion returned in the first nine months of the year [10][11] - K-Coffee has seen significant growth, with nearly 200 million cups sold in the first nine months, indicating strong potential for future expansion [5][23] Q&A Session Summary Question: Long-term focus on same-store sales vs. system sales - Management emphasizes the importance of both system sales and same-store sales, with a focus on transaction growth as a key driver for the business [13][14] Question: KFC pricing strategy and competition - Management notes that KFC's pricing strategy aims for stability, with slight adjustments based on market conditions and competition [16] Question: Franchising model and capital expenditure - The company is ready to increase the percentage of franchisee stores, which will help lower capital expenditure in the long term [17] Question: Q4 performance expectations - Management anticipates some top-line pressure in Q4 but remains confident in their ability to capture consumer needs and protect margins [19][20] Question: Food safety and cost control - The company prioritizes food safety and compliance, ensuring that quality is not compromised for cost control [22] Question: K-Coffee incremental benefits - K-Coffee has shown a single-digit sales uplift and produces incremental profit due to its unique operating model [23] Question: Pizza Hut store format performance - The Pizza Hut Valve store format is still in its early stages, with ongoing improvements in operational efficiency expected to enhance sales and profitability [24]
TOPSPORTS(06110) - 2025 H1 - Earnings Call Transcript
2024-10-24 01:00
Financial Data and Key Metrics Changes - The overall revenue fell by 7.9% to RMB 13.05 billion, primarily due to subdued macroeconomic demand and diminished foot traffic from offline customers [12][7] - Retail business revenue decreased by 8.9% to RMB 10.92 billion, while wholesale business revenue fell by 2.2% to RMB 2.04 billion [12] - The company registered a 35% decline in pretax profit, but operating cash flow rose by 2.5% [10][11] - The dividend payout ratio was 99.9%, maintaining a leading position in the industry [5][11] Business Line Data and Key Metrics Changes - The main brand sales revenue fell by 8.1% to RMB 11.35 billion, contributing 87.6% to total sales revenue, while other brands accounted for 12.4% of revenue, marking a slight rise of 0.2% [12] - The gross profit margin experienced a year-on-year decline of 3.6%, attributed to increased discount rates and a shift in sales distribution towards lower-margin wholesale channels [12][15] Market Data and Key Metrics Changes - The overall consumer market remains unclear, but supportive macroeconomic policies are anticipated to stimulate consumption [5][36] - The company noted a shift in consumer behavior from in-person to online shopping, which has increased the pressure on physical retail [36][37] Company Strategy and Development Direction - The company is committed to a flexible omni-channel strategy, enhancing integrated retail frameworks that merge online and offline channels [4][36] - There is a focus on broadening category layouts and solidifying market advantages across various sports sub-sectors [4][36] - The company aims to adapt to changing consumer preferences and enhance user experience through targeted optimizations [4][38] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges posed by a sluggish macroeconomic environment but expressed confidence in the long-term strategy and cash flow management [5][36] - The company anticipates beneficial shifts in the consumer market as macroeconomic policies take effect, despite the current unclear market conditions [5][36] - Management remains cautious about the second half of the year, projecting a potential decline in profits [86][87] Other Important Information - The company has maintained a strong cash generation capability, with net cash flow from operating activities reaching a billion, marking a 2.5% rise from the same period last year [28][29] - The number of directly operated stores decreased by 396, with a focus on optimizing store layouts and improving efficiency [41][40] Q&A Session Summary Question: Inventory management and new CEO impact - The company plans to work with brands facing inventory issues and is optimistic about the new CEO's potential to improve product innovation and market share in China [61][66][70] Question: Strategies for the November 11 shopping event - The company is mobilizing online and offline resources for the shopping event, acknowledging high industry inventory levels and the importance of this sales opportunity [73][74] Question: Market sentiment and consumer behavior changes - Management noted that government initiatives, such as consumption coupons, are positively impacting consumer sentiment, although quantifiable effects remain uncertain [75][90]
阜博集团20241009
2024-10-10 06:56
Financial Data and Key Metrics Changes - In 2023, the company's total revenue reached HKD 2 billion, with a gross margin of 42.5% [10] - For the first half of 2024, total revenue was HKD 1.18 billion, representing an 18% year-on-year growth, with subscription revenue at HKD 550 million and value-added revenue at HKD 164 million [10] - The net profit for the first half of 2024 was HKD 46.32 million, a 37% increase year-on-year [11] Business Line Data and Key Metrics Changes - The company has shifted its focus to content monetization since 2019, with this segment's revenue rapidly increasing to 60% of total revenue [4] - The company has maintained a customer retention rate of over 98% and achieved a compound annual growth rate of over 70% in revenue from 2021 to 2023 [10][21] Market Data and Key Metrics Changes - The Chinese capital market has shown a significant rebound, with the Hong Kong market outperforming the A-share market in terms of fundamental recovery and valuation changes [2] - The SaaS sector within the Hong Kong market has substantial potential for valuation recovery and expansion, particularly as valuations in the U.S. market have rebounded to 10-15 times price-to-sales ratios [2] Company Strategy and Development Direction - The company emphasizes a strategy of "foresight and implementation," focusing on AI applications and digital watermark technology since 2021 [5][23] - Future plans include strengthening AI-driven capabilities in copyright management and expanding market share in China through mergers and partnerships [5][30] Management's Comments on Operating Environment and Future Outlook - Management believes the current capital market environment presents both challenges and opportunities, with a strong fundamental performance that continues to attract investor interest [6] - The company is confident in its ability to maintain growth and will share further developments and strategies in future communications [6] Other Important Information - The company has established a Florida AI R&D center to enhance its capabilities in VIP content copyright management [5] - The company has formed strategic partnerships with major players like Ant Group to develop blockchain-based platforms for content rights management [5][12] Q&A Session Summary Question: What are the reasons for the rebound in the Chinese capital market and how is the Hong Kong market performing? - The Chinese capital market has rebounded significantly due to previous pressures on both the numerator and denominator, with the Hong Kong market showing better performance in fundamental recovery and valuation changes compared to the A-share market [2] Question: What is the business model and core competitiveness of the company? - The company is a leading provider of data asset protection and monetization services, focusing on helping content owners collect evidence of infringement and recover revenue from unauthorized use [3] Question: What are the company's future development directions? - The company will continue to enhance its capabilities in AI-driven information management and expand its market share in China through mergers and partnerships [5] Question: How does the company view the current capital market environment's impact on its operations? - The current capital market environment has some impact, but the company's fundamentals remain strong, and management is confident about future growth [6] Question: What are the company's key financial highlights? - The company has maintained a strong financial performance with a revenue model based on SaaS services, achieving significant growth and maintaining a high customer retention rate [21] Question: How does the company balance deepening existing customer relationships with expanding into new content areas? - The company focuses on large clients while gradually expanding into new categories, ensuring a balance between deepening existing relationships and exploring new opportunities [28]
ANTON OILFIELD(03337) - 2024 H1 - Earnings Call Transcript
2024-09-24 21:30
Financial Data and Key Metrics Changes - Revenue for the first half of 2024 was approximately RMB 2.2 billion, representing a 50% increase year-over-year [2] - Profit attributable to equity holders amounted to approximately RMB 106 million, an increase of 8.2% [2] - Free cash flow was RMB 197 million, reflecting a 15.2% increase compared to the same period last year [2] Business Line Data and Key Metrics Changes - Traditional businesses such as fracturing and drilling achieved operational records, with revenue from non-drilling rig services increasing by 24% [7] - Innovative businesses saw a 17% growth in revenues, with successful expansions into the Southeast Asian market [8] - The integrated oil field management project in Iraq was renewed for another year, indicating strong performance in innovative services [7] Market Data and Key Metrics Changes - The China market remained stable, focusing on natural gas and unconventional energy development [5] - The Iraq market experienced rapid growth as customers expanded production, contributing significantly to revenue [5] - The company expanded its presence in 14 new countries, capturing business opportunities and ensuring steady revenue growth in Africa, Southeast Asia, and Central Asia [6] Company Strategy and Development Direction - The company aims to expand into new global markets and upgrade services for green energy chains [13] - A focus on leveraging the Dufrya project to pursue new oil field management projects is part of the strategy [14] - The company is transitioning from traditional oil field solutions to green energy localized industry development in emerging markets [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the growth potential of the Iraqi market over the next five years, driven by larger-scale project opportunities [14] - The company plans to enhance profitability through refined operations and cash flow management [17] - Management highlighted the importance of digital sales efficiency in exploring new markets and cultivating growth opportunities [15] Other Important Information - The company resumed its dividend policy, paying out RMB 39 million in dividends and repurchasing 26 million shares, representing approximately 1% of total share capital [11][12] - Anton achieved recognition in ESG operations, being listed in S&P's sustainability yearbook 2024, marking a significant milestone for a Chinese oil service company [12] Q&A Session Summary Question: What is the focus for overseas market development and any new project opportunities? - The company sees stable growth in the China market and expects rapid growth in the Iraqi market over the next five years, while actively exploring new opportunities in over ten emerging countries [20][21] Question: What are the key dates and expected profits for the oil field project in Iraq? - The company has a clear timeline for the Dufrya oil field project, with expectations of stable returns over the next 25 years, not heavily affected by oil price fluctuations [30][31] Question: Has the company achieved large orders in the third quarter? - Orders have shown a good growth trend in the third quarter, with expectations for larger scale orders to be confirmed in the near future [32][34] Question: What is the plan for share buyback and separate listing? - The company plans to delay the separate listing due to strategic investor agreements but will continue to promote the listing process [36] Question: What is the company's cash flow management strategy? - The company has maintained a strong cash flow performance, with expectations for continued growth in free cash flow and effective cash flow operations [42][43]
江南布衣(03306) - 2023 Q4 - 业绩电话会
2024-09-06 02:30
Brand Portfolio and Strategy - The company has categorized its brand portfolio into three stages: mature brands (JMBY), growth brands (men's wear Su Xie, women's wear Less), and emerging brands (Penma, Relab, OMYGAME) [1] - Each brand has a unique brand language and market positioning, collectively building a diverse and rich brand matrix for the company [1] Business Lines and Market Positioning - The growth brands include Su Xie for men's wear and Less for women's wear, indicating a focus on expanding in the apparel sector [1] - Emerging brands such as Penma, Relab, and OMYGAME suggest the company is exploring new market segments and diversifying its offerings [1] Market and Industry Competition - The company's strategy of maintaining a diverse brand portfolio with distinct market positioning reflects a competitive approach to capture different consumer segments [1] Management Commentary and Future Outlook - No specific management commentary or future outlook was provided in the document [1] Other Important Information - No other significant information was mentioned in the document [1] Q&A Session - No Q&A session was recorded in the document [1]
歌礼制药(01672) - 2024 Q2 - 业绩电话会
2024-09-02 03:00
Financial Data and Key Metrics - The company's cash reserves as of June 30, 2024, exceeded RMB 2.1 billion, ensuring healthy operations and development for the next five years [1][2] - The company reported a loss of RMB 130 million in the first half of 2024, primarily due to increased R&D investments [1][2] - R&D personnel now account for 69% of the company's total workforce, reflecting a significant increase in R&D focus and efficiency [1][2] Business Line Data and Key Metrics - The company has focused on global BIC (Best-in-Class) and FIC (First-in-Class) pipeline development, particularly in metabolic diseases and oncology [1][2] - Key pipeline highlights include AAC40, which has successfully initiated Phase III trials, and AAC41, which showed promising Phase II results with 93.3% of patients achieving a 30% reduction in liver fat content [1][2] - The company has accelerated the development of global FIC and BIC candidates for metabolic diseases, with plans to continue this focus in the second half of 2024 [1][2] Market Data and Key Metrics - The company has engaged in extensive business development activities, including participation in major industry conferences such as the JP Morgan Healthcare Conference and the BioInnovation Biotechnology Innovation Organization's global PG conference [1][2] - A top-ten global chemical company expressed interest in the company's pipeline, selecting only 70 out of 1,000 biotech companies for meetings, with the company being one of the selected [1][2] Company Strategy and Industry Competition - The company's strategy is centered on global BIC and FIC pipeline development, avoiding "Me Too" drugs and focusing on top-tier competitive targets [1][2] - The company has increased its patent filings, with four new drug invention patents granted and 51 new applications filed in the first half of 2024, strengthening its competitive position [1][2] - The company plans to continue accelerating the development of global FIC and BIC candidates, particularly in metabolic diseases, to maintain its competitive edge [1][2] Management Commentary on Operating Environment and Future Outlook - Management emphasized the importance of healthy survival in a challenging industry environment, focusing on global BIC and FIC pipeline development and business development activities [1][2] - The company expects to complete key clinical milestones in the second half of 2024, including Phase III enrollment for AAC40 and Phase II completion for AAC41, with top-line data expected in the first half of 2025 [1][2] - Management expressed confidence in the company's cash reserves and R&D capabilities, aiming to maximize the value of its core pipelines before engaging in further business development activities [1][2] Other Important Information - The company has initiated a stock repurchase program, having already repurchased RMB 133 million worth of shares, with plans to continue repurchasing if cash reserves allow [1][2] - The company is exploring the potential of its AAC61 small molecule PD-L1 oral inhibitor, seeking potential partners following promising Phase I results [1][2] Summary of Q&A Session Question: What were the main projects driving the increase in R&D expenses in the first half of 2024? - The increase in R&D expenses was primarily driven by Phase III trials for AAC40, Phase II trials for AAC41, and the acceleration of global FIC and BIC candidate development for metabolic diseases [1][2] Question: When will the efficacy data for AAC40's Phase III trials be available? - Efficacy data for AAC40's Phase III trials is expected to be available in the first half of 2025, with safety follow-up data not impacting the efficacy data readout [1][2] Question: Is the company still working on the AS110 monkeypox project? - The company is conducting further internal evaluations of the AS110 monkeypox project, given the recent rise in monkeypox cases [1][2] Question: How does the company view the competition between its two NASH drugs and weight-loss drugs? - The company's NASH drugs (AAC40 and AAC41) are oral medications targeting liver fat reduction, while weight-loss drugs like GLP-1 are injectable and focus on weight management, indicating different market segments [1][2] Question: Will the company continue its stock repurchase program? - The company will prioritize R&D investments but may continue stock repurchases if cash reserves allow, with a focus on maintaining healthy operations and development [1][2] Question: When will the company form a commercialization team? - The company will consider forming a commercialization team once its pipelines receive regulatory approval, with a focus on global markets rather than domestic sales [1][2] Question: What are the company's future early-stage R&D pipeline plans? - The company's early-stage R&D pipeline will continue to focus on metabolic diseases, building on its current pipeline of AAC40 and AAC41 [1][2]
兴科蓉医药(06833) - 2024 Q2 - 业绩电话会
2024-09-02 02:30
Financial Data and Key Metrics Changes - The company's revenue increased by 40.1% to RMB 1.526 billion, with pharmaceutical sales contributing approximately RMB 439 million to this growth [1][2] - Gross profit rose by RMB 20.07 million to RMB 173 million, while net profit increased by RMB 4 million to RMB 23.9 million [1][2] Business Line Data and Key Metrics Changes - The pharmaceutical segment saw significant growth, particularly in human albumin sales, which reached RMB 440 million [2] - The aesthetic medicine segment is advancing with the clinical trial of the "girl needle" product, which has exceeded 50% enrollment as of June 30, 2023, and is expected to complete by mid-2025 [2][3] Market Data and Key Metrics Changes - The company holds a leading market position in blood products, with over 60% of the market relying on imports, indicating a strong demand for imported blood products [2][3] - The aesthetic medicine market is identified as having significant growth potential, particularly for injection products [2] Company Strategy and Development Direction - The company focuses on three main business segments: biopharmaceuticals, aesthetic medicine, and cold chain supply services, with plans to enhance its market position in each area [2][3] - The aesthetic medicine segment is seen as a high-potential market, with ongoing investments in product development and clinical trials [2] Management's Comments on Operating Environment and Future Outlook - Management noted that the demand for blood products is expected to grow, driven by increased awareness and recognition of these products post-pandemic [2] - The company anticipates stable growth in the blood products market, with a focus on maintaining its competitive edge through effective marketing and distribution channels [2][3] Other Important Information - The company has established a cold chain logistics service in Chengdu, which is expected to meet the growing demand for specialized cold chain services in the biopharmaceutical sector [2] - The company has acquired a medical beauty institution to enhance its research and development capabilities and direct access to end-users [2] Q&A Session Summary Question: Why was there no dividend declared this period? - Management explained that dividends are typically declared after annual audits and based on annual performance, indicating that future dividends will depend on cash flow and performance [2] Question: Will the focus shift more towards aesthetic medicine in the future? - Management clarified that while aesthetic medicine is a new and developing segment, the pharmaceutical segment remains stable and will continue to generate cash flow [2] Question: What are the company's advantages in the blood products sector? - Management highlighted the company's extensive experience, established marketing channels, and strong relationships with international suppliers as key competitive advantages [2] Question: What is the outlook for the human albumin business? - Management indicated that the market for human albumin is expected to grow, with increasing demand and reliance on imports, despite challenges in raw material sourcing [2] Question: Can you elaborate on the cold chain logistics business? - Management noted that the cold chain logistics segment is being developed to meet the growing demand for specialized services, particularly in the wake of the pandemic [2] Question: What is the current status of the aesthetic medicine business? - Management confirmed that the first product, the "girl needle," is on track for clinical trial completion and subsequent market entry, with confidence in its market potential [2]
嘀嗒出行(02559) - 2024 Q2 - 业绩电话会
2024-09-02 02:00
Financial Data and Key Metrics Changes - As of June 30, 2024, the company reported a total revenue of 4.04 billion, representing a year-on-year growth of 2% [1] - The adjusted net profit reached 1.3 billion, showing a significant increase of 51.3% year-on-year [1][2] - The gross margin was reported at 73.3%, a decrease of 3% compared to the previous year [2] Business Line Data and Key Metrics Changes - The ride-sharing business generated nearly 3.9 billion, accounting for 96.3% of total revenue, with a year-on-year growth of 4.1% [2] - The number of certified private car owners in the ride-sharing segment grew by 17% to 17.68 million [1] - The total transaction volume for the ride-sharing business reached 40 billion, with an order volume of 62 million [1] Market Data and Key Metrics Changes - The company operates ride-sharing services in 366 cities and has launched taxi-hailing services in 96 cities [1] - The company signed strategic cooperation agreements in 76 cities for its new taxi-hailing strategy [1] Company Strategy and Development Direction - The company aims to enhance operational efficiency by dynamically adjusting pricing and incentives based on supply-demand relationships [1] - Future strategies include deepening partnerships with reputable companies and expanding user base through various channels [1] - The company plans to explore carbon trading opportunities related to ride-sharing services [1] Management Comments on Operating Environment and Future Outlook - Management acknowledged external challenges such as a sluggish economy and competitive pressure from low-priced ride-hailing products [2] - The company is adjusting its market investment strategies to improve return on investment [2] - Management expressed confidence in the company's ability to share profits with shareholders through dividends or stock buybacks in the near future [2] Other Important Information - The company has a cash reserve of 1.66 billion, with a net cash position of 1 billion after accounting for user withdrawals and other payables [2] Q&A Session Summary Question: Future growth strategy given lower revenue growth compared to profit growth - Management attributed the slower revenue growth to external economic conditions and competitive pressures, while outlining a strategy focused on optimizing pricing and operations based on route characteristics [2] Question: Plans for shareholder returns - Management confirmed intentions to consider dividends or stock buybacks as a way to share profits with shareholders, given the strong cash flow and financial health [2] Question: Impact of autonomous driving on business - Management sees autonomous driving as a potential opportunity to enhance service efficiency and is exploring how to integrate this technology into their existing business model [2]
21世纪教育(01598) - 2024 Q2 - 业绩电话会
2024-09-02 02:00
Financial Data and Key Metrics Changes - As of June 30, 2024, the company's main business revenue reached 241 million, a 25.6% increase from 192 million in the same period of 2023 [1] - The overall gross profit was approximately 103 million, up 35.6% from 76.19 million year-on-year, with a gross margin increase of 3.2% [1] - EBITDA was about 94.51 million, a 3.4% increase from 91.41 million in the same period last year [1] - The net profit was approximately 30.78 million, a slight decrease of 2.58 million compared to 33.37 million in the same period of 2023 [1] Business Line Data and Key Metrics Changes - The vocational education segment generated 173 million in revenue, a significant increase of 38.8%, accounting for 72% of total revenue, up 7% from the previous year [1] - Non-vocational education revenue was approximately 68.55 million, a modest increase of 1.4% year-on-year [1] - The average tuition fee in the vocational education segment increased by 39.8%, while accommodation fees rose by 57.6% due to improved living conditions [1] Market Data and Key Metrics Changes - The total number of full-time students increased from 23,423 to 24,439, a growth of 4.3% year-on-year [1] - The employment rate for graduates reached 96.8%, a new high [1] Company Strategy and Development Direction - The company aims to expand its internal growth while optimizing its business and exploring external development opportunities [1] - The focus is on integrating educational resources and enhancing vocational education services, while also responding to national policies supporting private vocational education [1] - The company plans to enhance brand building and establish a unique educational brand with significant influence [1] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in maintaining strong growth in student numbers and tuition fees due to the quality of education and course offerings [1] - The company anticipates a double-digit revenue growth for the full year, with vocational education revenue expected to grow over 25% [1] Other Important Information - The company has initiated the construction of a new campus, which is expected to accommodate over 12,000 additional students [1] - The company is actively involved in industry partnerships and collaborations to enhance educational quality and employment outcomes for graduates [1] Q&A Session All Questions and Answers Question: What is the outlook for maintaining high tuition fee growth? - Management indicated that tuition fee increases are based on student growth and improved course quality, with expectations for continued growth in both student numbers and average tuition fees [1] Question: What are the reasons for the revenue growth this year? - Revenue growth was primarily driven by the vocational education segment, with significant increases in student enrollment and tuition fees [1] Question: What is the progress on the new campus construction? - The new campus construction is underway, with plans to increase student capacity significantly [1] Question: What is the current asset-liability ratio and future improvement plans? - The asset-liability ratio decreased to 63.7%, and the company will continue to monitor and manage this ratio for operational stability [1] Question: What are the latest developments regarding the classification of the vocational college? - The college has expressed its intention to classify as a for-profit institution, pending further instructions from the education authorities [1] Question: How does the company plan to ensure educational quality with increasing student capacity? - The college is focusing on high-level professional development, infrastructure improvements, and enhancing faculty quality to maintain educational standards [1] Question: What are the company's plans for the next five years? - The company aims to expand its educational offerings and explore acquisition opportunities while enhancing its brand and operational capabilities [1]
中升控股(00881) - 2024 Q2 - 业绩电话会
2024-08-30 08:00
各位投资人分析师大家下午好欢迎大家参加中生集团控股有限公司2024年中期线上业绩发布会本次会议设置英文同声传译大家可以自行选择字幕传译功能中的中英文频道进行切换首先为大家介绍今天出席本次会议的公司管理层他们分别是中生控股董事会主席黄毅先生 和首席战略官周正先生那今天会议的前半程将由两位管理层为大家介绍公司上半年业绩情况后半程我们设置了问答环节届时欢迎大家提问首先分别有请黄毅先生和周正先生发言各位股东各位关注我们终身的朋友们大家下午好 我是公司董事会主席黄毅感谢各位来参加我们的业绩发布会今天中午我们发出了我们的中期的业绩报告相信大家都可以看到在今年这么严峻的市场情况下东森依然取得了16个亿的净利润在汽车服务的各个方面我们都取得了 明显的成绩这证明了我们的战略方针是正确的坚定了我们做终身品牌化汽车服务的决心在这里我也借此机会感谢各位投资人及合作伙伴的信任和支持同时也很感谢我们全体员工的辛苦付出和努力接下来我把时间交给我们的首席战略官周正 由他来具体介绍一下我们2024年上半年的业绩表现感谢黄主席各位朋友大家好我是周震下面由我来为大家介绍一下我们2024年中期业绩的情况 首先在这边先提醒一下我们这里投屏的这份材料和 ...